Illumina Q3 revenue $1.12B (+1% YoY); GAAP EPS -$24.26 on $3.91B GRAIL goodwill impairment

ILLUMINA, INC.

2022-Q3 EPS reported -$27.13 revenue$3,501,000,000

GAAP diluted loss per share of $(24.26) vs. income of $2.08 in Q3 2021, driven by $3.91B goodwill impairment for GRAIL segment.
Non-GAAP diluted EPS of $0.34, down from $1.45; revenue $1.115B, up 1% reported and 3% constant currency.
Full-year FY2022 guidance: revenue flat to +1% YoY; GAAP EPS loss $(26.56)-$(26.41); non-GAAP EPS $2.35-$2.50.
50 NovaSeq X orders received; management expects macro headwinds to continue into 2023.
Consolidated GRAIL results included; GAAP gross margin 64.3% vs 69.5% YoY; operating margin -327.9%.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

ILLUMINA, INC. reported third quarter ended October 2, 2022 results: revenue $1.12 billion, net income $ (3,816), EPS $(24.26). Guidance initiated.

Period: third quarter ended October 2, 2022
Revenue: $1.12 billion
Net income: $ (3,816)
EPS: $(24.26)
Guidance: initiated
Result: reported results

Exact text from the filing

Illumina Reports Financial Results for Third Quarter of Fiscal Year 2022 • Revenue of $1.12 billion for Q3 2022, up 1% from Q3 2021, and up 3% on a constant currency basis • GAAP diluted loss per share of $(24.26) for Q3 2022, compared to GAAP diluted earnings per share of $2.08 for Q3 2021; GAAP diluted loss per share for Q3 2022 includes goodwill impairment of $3.91 billion related to the GRAIL segment • Non-GAAP diluted earnings per share of $0.34 for Q3 2022, compared to non-GAAP diluted earnings per share of $1.45 for Q3 2021 • Expect full year revenue for fiscal year 2022 to be flat to 1% higher compared to fiscal year 2021, primarily reflecting year-to-date growth in sequencing consumables revenue, largely offset by a fourth quarter decline in select research project sample volume; delayed purchases ahead of the upcoming availability of NovaSeq X and from customer inventory and capital management; and incremental foreign exchange headwinds • Expect GAAP diluted loss per share of

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

ILLUMINA, INC. filing history →

Source: SEC EDGAR

accession 0001110803-22-000045

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.